Clinical Practice Guideline – Peripheral T- and Natural Killer-ce
Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines
Related Articles
Caring for underserved cancer patient populations
ESMO continues its commitment to gender-diverse and sex-specific oncology to address the growing need to close knowledge gaps among oncologists
Clinical Practice Guideline – Peripheral T- and Natural Killer-ce
Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines
Research offers novel insights to refine first-line treatment in GEP-NETs
Data from new clinical trials reported positive results of radioligand therapy over everolimus and sunitinib, and explore the combination of everolimus and somatostatin analogues
Molecular Analysis for Precision Oncology Congress 2025: Abstracts
The abstract submission system is now open
Enrico Franceschi | ESMO
Enrico Franceschi,MD, is a medical oncologist, Chairman of the Nervous System Medical Oncology Department of IRCCS Istituto delle Scienze Neurologiche
ESMO Deep Dive: Lung Cancer – Advanced Non-small-Cell Lung Cancer
This ESMO Webinar Series is available to all ESMO Members